To receive regular updates

In this episode, Matthew Blosl, CEO of DexCare, discusses how he helps high-growth healthcare technology companies navigate critical inflection points by pairing disciplined focus with a culture that embraces failure as a path to innovation. He describes DexCare’s journey from a Providence Health incubated initiative to a scaled care orchestration platform that helps health systems address a “trilemma” of rising patient demand, clinician shortages, and margin pressure.

Matt explains DexCare’s co-innovation model, where every health system becomes an innovation partner rather than a one-size-fits-all implementation, enabled by modern data and AI capabilities. He outlines a pragmatic AI roadmap: first improving internal operations, then enhancing existing products, and finally accelerating true product innovation, while warning that AI can easily drive teams off-mission without strong focus. Matt also points out how fast things are shifting in healthcare and encourages leaders to rethink how they run their organizations and come together more often to tackle the challenges ahead. Take a listen. 

Matthew Blosl is Chief Executive Officer and a board member of DexCare, the leading digital platform for orchestrating patient demand and care access. With over 20 years of executive leadership experience in technology-driven organizations, Blosl is recognized for building high-performing teams, scaling commercial operations, and driving strategic growth that delivers measurable customer and enterprise value.

Prior to joining DexCare, Blosl held a senior leadership role at Experity, where he led commercial initiatives that significantly expanded the company’s market presence and helped secure its leadership position in the urgent care space. Throughout his career, he has fostered cultures of operational excellence and innovation, consistently delivering results in high-growth environments.

Blosl holds a degree in engineering from the University of Michigan and completed his business education at Stanford Graduate School of Business. He brings a powerful combination of technical rigor and strategic acumen to his leadership, grounded in a passion for transforming healthcare access and outcomes.

At DexCare, Blosl is leading the company into its next phase of growth, focused on expanding platform innovation—including the introduction of AI-driven capabilities—and deepening adoption across leading U.S. health systems. Under his leadership, DexCare continues to transform how patients find and access the right care, at the right time, with the right provider.